Chicago emerging as a life science and biopharma hub

By Jane Byrne

- Last updated on GMT

Chicago emerging as life science and biopharma hub

Related tags cell and gene therapy chicago Innovation Biopharma hub

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.

In fact, in recent times, tens of billions of dollars have flooded into the Midwest to accelerate life sciences innovation, and Illinois is ranked in the top 10 states in funding from the US National Institutes of Health.

In the second episode of our newly launched broadcast series, The BioPharma Hub, I am joined by two eminent industry professionals who call Chicago home.

They provide a deep dive into the windy city's standing in the life science space.

Anshul Mangal, is president of Project Farma - a consulting firm providing biomanufacturing strategy and execution and alongside that role he is president of Precision ADVANCE. He pioneered the industrialization of two FDA-approved cell and gene therapies.

Also chatting to us is Tony Khoury, executive vice president, Project Farma. Khoury is a life sciences industry veteran, with vast experience in biologics and advanced therapies.

Tune in to hear more.

Related news

Show more

Related products

show more

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Related suppliers

Follow us


View more